Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepa Manwani

Showing results (111-120 of 138) with videos related to

Pageof 14
Sort By:
Biorxiv : the Preprint Server for Biology|April 27, 2026
Distinct prokaryotic gut microbiome and proviral-immune axes of pathophysiology in Sickle Cell DiseaseZachary N Flamholz, Jennifer De Los Santos, Karen Ireland, et al.
American Journal of Hematology|March 29, 2014
A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell diseaseMarvin E Reid, Amal El Beshlawy, Adlette Inati, et al.
British Journal of Haematology|April 21, 2018
Novel findings from the multinational DOVE study on geographic and age-related differences in pain perception and analgesic usage in children with sickle cell anaemiaJulie Kanter, Lori E Heath, Jack Knorr, et al.
Annals of Hematology|April 20, 2024
Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi panelJulie Kanter, Kenneth I Ataga, Neha Bhasin, et al.
Academic Pediatrics|August 14, 2021
Transition Navigator Intervention Improves Transition Readiness to Adult Care for Youth With Sickle Cell DiseaseDeepa Manwani, Maya H Doyle, Lynn Davidson, et al.
Plos One|February 15, 2013
Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyureaNancy S Green, Katherine L Ender, Farzana Pashankar, et al.
Frontiers in Immunology|October 13, 2025
Higher aged neutrophils and differential inflammatory profiles in sickle cell disease patients on chronic transfusion therapy versus those on hydroxyureaKatrina Terrigno, Zachary N Flamholz, Aakash Mahant Mahant, et al.
The Journal of Clinical Investigation|July 25, 2023
Hemolysis dictates monocyte differentiation via two distinct pathways in sickle cell disease vaso-occlusionYunfeng Liu, Shan Su, Sarah Shayo, et al.
Cells|September 29, 2020
Characterization of Hematopoiesis in Sickle Cell Disease by Prospective Isolation of Stem and Progenitor CellsSeda S Tolu, Kai Wang, Zi Yan, et al.
Blood Advances|February 11, 2021
Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infectionCaterina P Minniti, Ahmar U Zaidi, Mehdi Nouraie, et al.
Pageof 14

Showing results (111-120 of 138) with videos related to

Sort By:
Pageof 14
Biorxiv : the Preprint Server for Biology|April 27, 2026
Distinct prokaryotic gut microbiome and proviral-immune axes of pathophysiology in Sickle Cell DiseaseZachary N Flamholz, Jennifer De Los Santos, Karen Ireland, et al.
American Journal of Hematology|March 29, 2014
A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell diseaseMarvin E Reid, Amal El Beshlawy, Adlette Inati, et al.
British Journal of Haematology|April 21, 2018
Novel findings from the multinational DOVE study on geographic and age-related differences in pain perception and analgesic usage in children with sickle cell anaemiaJulie Kanter, Lori E Heath, Jack Knorr, et al.
Annals of Hematology|April 20, 2024
Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi panelJulie Kanter, Kenneth I Ataga, Neha Bhasin, et al.
Academic Pediatrics|August 14, 2021
Transition Navigator Intervention Improves Transition Readiness to Adult Care for Youth With Sickle Cell DiseaseDeepa Manwani, Maya H Doyle, Lynn Davidson, et al.
Plos One|February 15, 2013
Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyureaNancy S Green, Katherine L Ender, Farzana Pashankar, et al.
Frontiers in Immunology|October 13, 2025
Higher aged neutrophils and differential inflammatory profiles in sickle cell disease patients on chronic transfusion therapy versus those on hydroxyureaKatrina Terrigno, Zachary N Flamholz, Aakash Mahant Mahant, et al.
The Journal of Clinical Investigation|July 25, 2023
Hemolysis dictates monocyte differentiation via two distinct pathways in sickle cell disease vaso-occlusionYunfeng Liu, Shan Su, Sarah Shayo, et al.
Cells|September 29, 2020
Characterization of Hematopoiesis in Sickle Cell Disease by Prospective Isolation of Stem and Progenitor CellsSeda S Tolu, Kai Wang, Zi Yan, et al.
Blood Advances|February 11, 2021
Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infectionCaterina P Minniti, Ahmar U Zaidi, Mehdi Nouraie, et al.
Pageof 14